ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.766,79
-0,58%
S&P 500
5.300,81
1,03%
US Dollar vs BRL
5,1355
0,12%
Bitcoin
65.331,62
6,15%
Brent Oil
82,565
0,02%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Reino Unido
  5. AQSE
  6. Apollon Formularies plc (APOL)

  7. Apollon Formularies plc (APOL) Notícias

APOL

Apollon Formularies (APOL)

Apollon Formularies plc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:AQSE:APOL
DataHoraFonteTítuloCódigoCompanhia
03/05/202408:59UK RegulatoryApollon Formularies Plc - Notice of GMAQSE:APOLApollon Formularies plc
01/05/202411:00UK RegulatoryApollon Formularies Plc - Intention to Withdraw from AQUISAQSE:APOLApollon Formularies plc
20/02/202407:59UK RegulatoryApollon Formularies Plc - CANCER CELL KILLING RESULTS PUBLISHED IN THE PEER-REVIEWED ONLINE JOURNAL OF COMPLEMENTARY AND ALTERNATIVE MEDICINE (OJCAM)AQSE:APOLApollon Formularies plc
02/01/202405:18UK RegulatoryApollon Formularies Plc Result of AGMAQSE:APOLApollon Formularies plc
05/12/202308:59UK RegulatoryApollon Formularies Plc Notice of AGMAQSE:APOLApollon Formularies plc
21/11/202308:51UK RegulatoryApollon Formularies Plc Sproutly and Apollon Conclude Due Diligence, Paving Way for Asset Purchase AgreementAQSE:APOLApollon Formularies plc
29/09/202303:00UK RegulatoryApollon Formularies Plc Interim Results for the 6 Months ended 30 June 2023AQSE:APOLApollon Formularies plc
19/09/202305:18UK RegulatoryApollon Formularies Plc Execution of Binding LOI with Sproutly Canada, Inc.AQSE:APOLApollon Formularies plc
03/08/202306:51UK RegulatoryApollon Formularies Plc Resignation of Non-Executive DirectorAQSE:APOLApollon Formularies plc
02/08/202308:19UK RegulatoryApollon Formularies Plc Update on Global Hemp GroupAQSE:APOLApollon Formularies plc
24/07/202307:00UK RegulatoryApollon Formularies Plc Apollon grants an Exclusive Licence Agreement to PureCann, South AfricaAQSE:APOLApollon Formularies plc
30/06/202313:32UK RegulatoryApollon Formularies plc Final Results for the Year Ended 31 December 2022AQSE:APOLApollon Formularies plc
11/04/202310:00UK RegulatoryApollon Formularies Plc Result of General MeetingAQSE:APOLApollon Formularies plc
21/03/202309:00UK RegulatoryApollon Formularies Plc 28 day due diligence extension for Asset saleAQSE:APOLApollon Formularies plc
15/03/202304:00UK RegulatoryApollon Formularies plc Notice of General MeetingAQSE:APOLApollon Formularies plc
12/01/202304:00UK RegulatoryApollon Formularies plc Execution of Binding Letter of Intent with GHGAQSE:APOLApollon Formularies plc
30/12/202209:37UK RegulatoryApollon Formularies plc Result of AGMAQSE:APOLApollon Formularies plc
02/12/202204:00UK RegulatoryApollon Formularies plc Notice of AGMAQSE:APOLApollon Formularies plc
30/09/202205:50UK RegulatoryApollon Formularies plc Interim ResultsAQSE:APOLApollon Formularies plc
13/09/202203:02UK RegulatoryApollon Formularies plc Directors' DealingAQSE:APOLApollon Formularies plc
02/08/202205:11UK RegulatoryApollon Formularies plc Total Voting RightsAQSE:APOLApollon Formularies plc
26/07/202203:00UK RegulatoryApollon Formularies plc Acquisition of Citiva & Director Loan AgreementAQSE:APOLApollon Formularies plc
30/06/202212:29UK RegulatoryApollon Formularies plc Final ResultsAQSE:APOLApollon Formularies plc
30/06/202208:33UK RegulatoryApollon Formularies Plc Total Voting RightsAQSE:APOLApollon Formularies plc
17/06/202209:23UK RegulatoryApollon Formularies plc Issue of EquityAQSE:APOLApollon Formularies plc
05/05/202208:07UK RegulatoryApollon Formularies plc Apollon Acquires Intellectual Property from AionAQSE:APOLApollon Formularies plc
02/03/202204:01UK RegulatoryApollon Formularies plc Joint Venture with Tri-Medi Canna, South AfricaAQSE:APOLApollon Formularies plc
09/02/202204:00UK RegulatoryApollon Formularies plc Intention to Join OTC & Migrate to Larger ExchangeAQSE:APOLApollon Formularies plc
03/02/202203:59UK RegulatoryApollon Formularies plc Grand Opening of International Cancer InstituteAQSE:APOLApollon Formularies plc
27/01/202204:00UK RegulatoryApollon Formularies plc Chief Science Officer Appointed as Board DirectorAQSE:APOLApollon Formularies plc
 Apresentando as notícias mais relevantes sobre:AQSE:APOL

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
AZEV4
AZEVEDO PN
BOV
LUPA3
LUPATECH ON
BOV
HAGA3
HAGA ON
BOV
PETR4
PETROBRAS PN
BOV
COGN3
COGNA ON
BOV
PRIO3
PETRORIO ON
BOV
SEQL3
Sequoia Logistica e Tran... ON
BOV
AMAR3
LOJAS MARISA ON
BOV
ETER3
ETERNIT ON
BOV
HBOR3
HELBOR ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
GFSA3
GAFISA ON
BOV
AZEV3
AZEVEDO ON
BOV
GOLL4
GOL PN
BOV
TELB4
TELEBRAS PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados